Kimia Heydari, Elizabeth J. Enichen, Ben Li, Joseph C. Kvedar
{"title":"了解心率变异性与月经规律性之间关系的新指标","authors":"Kimia Heydari, Elizabeth J. Enichen, Ben Li, Joseph C. Kvedar","doi":"10.1038/s41746-025-01517-1","DOIUrl":null,"url":null,"abstract":"Cardiovascular disease is underdiagnosed and undertreated in women compared to men. Wearable technologies (wearables) help shed light on women’s cardiovascular by collecting continuous cardiovascular data and correlating it with hormonal fluctuations across the menstrual cycle. In this context, Jasinski et al. propose that the new metric, cardiovascular amplitude, enables non-invasive monitoring of female physiology and health across the menstrual cycle.","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":"50 1","pages":""},"PeriodicalIF":12.4000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A new metric to understand the association between heart rate variability and menstrual regularity\",\"authors\":\"Kimia Heydari, Elizabeth J. Enichen, Ben Li, Joseph C. Kvedar\",\"doi\":\"10.1038/s41746-025-01517-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cardiovascular disease is underdiagnosed and undertreated in women compared to men. Wearable technologies (wearables) help shed light on women’s cardiovascular by collecting continuous cardiovascular data and correlating it with hormonal fluctuations across the menstrual cycle. In this context, Jasinski et al. propose that the new metric, cardiovascular amplitude, enables non-invasive monitoring of female physiology and health across the menstrual cycle.\",\"PeriodicalId\":19349,\"journal\":{\"name\":\"NPJ Digital Medicine\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":12.4000,\"publicationDate\":\"2025-02-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Digital Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41746-025-01517-1\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41746-025-01517-1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
A new metric to understand the association between heart rate variability and menstrual regularity
Cardiovascular disease is underdiagnosed and undertreated in women compared to men. Wearable technologies (wearables) help shed light on women’s cardiovascular by collecting continuous cardiovascular data and correlating it with hormonal fluctuations across the menstrual cycle. In this context, Jasinski et al. propose that the new metric, cardiovascular amplitude, enables non-invasive monitoring of female physiology and health across the menstrual cycle.
期刊介绍:
npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics.
The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.